Overview

A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants

Status:
Completed

Trial end date:
2020-10-20

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the one-way drug-drug interaction potential of quizartinib on dabigatran etexilate in healthy adult participants.

Phase:

Early Phase 1

Details

Lead Sponsor:

Daiichi Sankyo Co., Ltd.

Treatments:

Dabigatran